Nevertheless, in our study, data were pooled using the following common criteria: (1) patients with defined hypertension plus T2DM; (2) available data for indicators including BP, UACR, and NT-proBNP; and (3), available results at the 12-week time point. The gene discussed is NPPB; the disease is Hypertension.